Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Monotherapy with gabapentin ++].

L Padró1, R Rovira

  • 1Servicio de Neurología, Hospital General Universitari Vall d'Hebron, Barcelona, España.

Revista De Neurologia
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An institutional study: Does Body Mass Index influence surgical approach, surgical morbidities, and outcomes in endometrial cancer patients?

Facts, views & vision in ObGyn·2023
Same author

High consumption foods and their influence on energy and protein intake in institutionalized older adults.

The journal of nutrition, health & aging·2012
Same author

Diagnosis of epileptic syndrome after a new onset seizure and its correlation at long-term follow-up: longitudinal study of 131 patients from the emergency room.

Epilepsy research·2011
Same author

[Focal hyperperfusion associated to ictal periodic lateralised epileptiform discharges].

Revista de neurologia·2011
Same author

Bacterial community analysis of a gas-phase biotrickling filter for biogas mimics desulfurization through the rRNA approach.

Chemosphere·2010
Same author

Intravascular large B-cell lymphoma presenting with neurological syndromes: clinicopathologic study.

Clinical neuropathology·2007
Same journal

The Correlation Between and Variability of Three Balance Scales in the Assessment of Balance Function in Patients With Ataxia.

Revista de neurologia·2026
Same journal

Surgical Treatment of an Aneurysm in the Subacute Stage of Hemorrhagic Moyamoya Disease: Aneurysm Resection Combined With STA-MCA Bypass: A Case Report.

Revista de neurologia·2026
Same journal

Mapping the Evidence: Central Sleep Apnea Syndromes During Sleep and Stroke-A Scoping Review.

Revista de neurologia·2026
Same journal

Developmental and Epileptic Encephalopathy Due to a Novel <i>ARHGEF9</i> Deletion Variant: Case Series of Two Siblings.

Revista de neurologia·2026
Same journal

P300 Event-Related Potentials as Cognitive Biomarkers in Neurological and Neuropsychiatric Disorders: A Systematic Review.

Revista de neurologia·2026
Same journal

[Effectiveness and Risk of Recurrence of Pulsed Radiofrequency in Trigeminal Neuralgia and Chronic Cluster Headache].

Revista de neurologia·2026
See all related articles

Gabapentin is an effective anti-epileptic drug for monotherapy in partial onset seizures. Newly diagnosed patients benefit from an initial dose of 900 mg/day, with a favorable safety profile compared to carbamazepine.

Area of Science:

  • Pharmacology
  • Clinical Neurology
  • Epileptology

Background:

  • Gabapentin, an anti-epileptic drug, was initially approved for adjunctive therapy in partial onset seizures.
  • Recent approvals have expanded its use to monotherapy, necessitating a review of its efficacy and safety in this context.

Purpose of the Study:

  • To review the characteristics of gabapentin as an anti-epileptic agent.
  • To analyze clinical trials supporting its monotherapy indications.

Main Methods:

  • Review of clinical trial design challenges for antiepileptic monotherapy, including ethical and technical considerations.
  • Analysis of trials evaluating gabapentin monotherapy in drug-resistant patients, pre-surgical patients, and newly diagnosed patients.

Main Results:

Related Experiment Videos

  • Monotherapy trials presented challenges but suggested efficacy.
  • Higher doses (3,600 mg/day) were found safe and effective in pre-surgical patients.
  • Efficacy and safety of various dosages were confirmed in newly diagnosed patients.

Conclusions:

  • Gabapentin demonstrates effectiveness as monotherapy for partial onset seizures.
  • Recommended initial dose for newly diagnosed patients is 900 mg/day.
  • Gabapentin offers a superior safety profile to carbamazepine and is indicated for simple and complex partial seizures.